Boehringer Ingelheim
Other
Active
Ingelheim am Rhein, Germany
10
110M
8
0.07
0.10
2
- Areas of investment
Summary
Boehringer Ingelheim appeared to be the Corporate Investor, which was created in 1885. The venture was found in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Ingelheim Am Rhein.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Boehringer Ingelheim, startups are often financed by Vesalius Biocapital Partners, Shire, S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are Shire, SFPI-FPIM, PPF Group. In the next rounds fund is usually obtained by Vesalius Biocapital Partners, Shinsei Corporate Investment Limited, Shibuya Kogyo.
The top activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2018.
The fund has exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight MabVax Therapeutics, Promethera Biosciences. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.07
- Follow on index
- 0.10
- Investments by industry
- Biotechnology (6)
- Health Care (6)
- Therapeutics (5)
- Pharmaceutical (4)
- Medical Device (3) Show 10 more
- Investments by region
-
- United States (5)
- Belgium (1)
- Switzerland (1)
- Kenya (1)
- Austria (1) Show 1 more
- Peak activity year
- 2020
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 177M
- Group Appearance index
- 0.60
- Avg. company exit year
- 8
- Avg. multiplicator
- 20.56
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| TeleVet | 31 Aug 2023 | Health Care, Medical, Veterinary | Early Stage Venture | 43M | United States, Texas, Austin |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.